Project Grant HT94252410655
Award Date 8/1/24
Completion Date 7/31/27
Dollars Obligated $1.5M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), has been awarded a $1,000,236.00 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant, effective April 1, 2024 through March 31, 2028, will fund research to "UNLOCK THE CTDNA MUTATIONAL PATTERNS FOR EARLY CANCER DETECTION AND NONINVASIVE BIOMARKERS." As a leading academic medical center and research...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,234,505 project grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research titled "COTARGETING THE TUMOR MICROENVIRONMENT TO REVOLUTIONIZE ANTIBODY-DRUG CONJUGATE THERAPY FOR REFRACTORY BREAST CANCERS". The award, funded through the Military Medical Research and Development program (CFDA 12.420), aims to transform healthcare for military service members,...
- The Massachusetts General Hospital will receive $826,584 under a three-year Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research into the mechanisms mediating the immune response after proton versus photon radiotherapy in IDH-mutant liver cancer. The study aims to investigate medical solutions for the battlefield and transform health care for service members and the public through innovative...
- This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $730,033 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for research to develop therapies targeting AMH signaling within the ovarian cancer tumor microenvironment. The award has a performance period from April 15, 2024 to April 14, 2027. As part of its extensive biomedical research portfolio,...
- The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $1,865,846 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on July 1, 2024. The funding will support the project "TARGETING NEUROIMMUNE AND EPITHELIAL SIGNALING FOR ECZEMA TREATMENT" through June 30, 2028. MGH, a leading academic medical center and research institution, will conduct biomedical research,...
- This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program provides $320,000.00 in funding to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research on "GAMMA DELTA T CELL LIGANDS IN MS". The award period runs from November 1, 2024 to October 31, 2026. As a major recipient of federal research funding, MGH will leverage its extensive...
- This Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program provides $819,980.00 in funding to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct research on elucidating sex differences in melanoma tumorigenesis. The 3-year research project, beginning on August 15, 2024 and ending on August 14, 2027, aims to advance the understanding and treatment of this complex...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Massachusetts General Hospital (MGH) a Project Grant totaling $382,381 on September 1, 2025, under the Military Medical Research and Development program (CFDA 12.420) to support research on "Genetic Immunodetection and Treatment of VCA Rejection." The three-year award, scheduled for completion by August 31, 2028, funds advanced biomedical research designed to advance healthcare solutions relevant to military...
- This $1,644,309 Project Grant was awarded on February 1, 2025 by the Defense Health Agency, which administers the Military Medical Research and Development program (CFDA 12.420), to The General Hospital Corporation (doing business as Massachusetts General Hospital) in Boston, MA. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the research will focus on functional molecular networks...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Massachusetts General Hospital (MGH) a $771,627 Project Grant effective August 1, 2025, through July 31, 2027, under the Military Medical Research and Development program (CFDA 12.420). This award supports research on "Tune and Strike Targeting of Glioblastoma," a project focused on advanced biomedical research aimed at developing innovative diagnostic and therapeutic approaches for glioblastoma, an...